CJ Bioscience to acquire remaining EzBiome, Inc. (US) shares for ₩7.6bn

CJ Bioscience · KOSDAQ · 311690 · Nov 10, 2026 · Equity acquisitions and disposals

CJ Bioscience filed to acquire 185,667 shares of EzBiome, Inc. (US) for ₩7.6bn, equal to 14.1% of its equity, which would raise its stake to 100.0%. The expected date is Nov 23, 2026, and the stated purpose is repayment of subsidiary borrowings and liquidation. By our calculation, the deal amount is 204.5% of FY2025 revenue.

Key facts

Target companyEzBiome, Inc. (US)
Shares185,667 shares
Deal amount₩7.6bn
% of equity14.1%
Stake after100.0%
PurposeRepayment of subsidiary borrowings and liquidation
Expected dateNov 23, 2026

Comparison

Amount as % of FY2025 revenue (calculated)204.5%
Revenue 2025₩3.7bn
Revenue 2024₩3.5bn
Revenue 2023₩5.6bn

Context

Q3 2026 revenue was ₩863m, up 16.9% year on year, and the operating loss for Q3 2026 was ₩4.9bn.

Source: DART (Financial Supervisory Service) · Original filing on DART ↗ (opens the Financial Supervisory Service's DART site)